Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response

Pyridostigmine, a carbamate acetylcholinesterase (AChE) inhibitor, is routinely employed in the treatment of the autoimmune disease myasthenia gravis1. Pyridostigmine is also recommended by most Western armies for use as pretreatment under threat of chemical warfare, because of its protective effect against organophosphate poisoning2,3. Because of this drug's quaternary ammonium group, which prevents its penetration through the blood–brain barrier, the symptoms associated with its routine use primarily reflect perturbations in peripheral nervous system functions1,4. Unexpectedly, under a similar regimen, pyridostigmine administration during the Persian Gulf War resulted in a greater than threefold increase in the frequency of reported central nervous system symptoms5. This increase was not due to enhanced absorption (or decreased elimination) of the drug, because the inhibition efficacy of serum butyrylcholinesterase was not modified5. Because previous animal studies have shown stress–induced disruption of the blood–brain barrier6, an alternative possibility was that the stress situation associated with war allowed pyridostigmine penetration into the brain. Here we report that after mice were subjected to a forced swim protocol (shown previously to simulate stress7), an increase in blood–brain barrier permeability reduced the pyridostigmine dose required to inhibit mouse brain AChE activity by 50% to less than 1/100th of the usual dose. Under these conditions, peripherally administered pyridostigmine increased the brain levels of c–fos oncogene and AChE mRNAs. Moreover, in vitro exposure to pyridostigmine increased both electrical excitability and c–fos mRNA levels in brain slices, demonstrating that the observed changes could be directly induced by pyridostigmine. These findings suggest that peripherally acting drugs administered under stress may reach the brain and affect centrally controlled functions.

[1]  R G Borland,et al.  Studies on the Possible Central and Peripheral Effects in Man of a Cholinesterase Inhibitor (Pyridostigmine) , 1985, Human toxicology.

[2]  H. Soreq,et al.  Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3'-terminal exons , 1995, Molecular and cellular biology.

[3]  H. Soreq,et al.  Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  B. McEwen,et al.  Stress and cognitive function , 1995, Current Opinion in Neurobiology.

[5]  P. K. Dey,et al.  Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats , 1991, Neuroscience Research.

[6]  M. Fioravanti,et al.  Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study. , 1983, Clinical neuropharmacology.

[7]  M. Waterman,et al.  Adrenaline stimulates cholesterol side-chain cleavage cytochrome P450 mRNA accumulation in bovine adrenocortical cells. , 1991, The Journal of endocrinology.

[8]  R. Kalaria,et al.  Blood‐Brain Barrier Abnormalities in Alzheimer's Disease a , 1991, Annals of the New York Academy of Sciences.

[9]  Osamu Uyama,et al.  Quantitative Evaluation of Vascular Permeability in the Gerbil Brain after Transient Ischemia Using Evans Blue Fluorescence , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  C. Eaton,et al.  Regulation of prostate growth. , 1991, The Journal of endocrinology.

[11]  P. Brust Blood-brain barrier transport under different physiological and pathophysiological circumstances including ischemia. , 1991, Experimentelle Pathologie.

[12]  P. DIRNHUBER,et al.  The protection of primates against soman poisoning by pretreatment with pyridostigmine , 1979, The Journal of pharmacy and pharmacology.

[13]  D. Ben-Nathan,et al.  Stress-induced neuroinvasiveness of a neurovirulent noninvasive Sindbis virus in cold or isolation subjected mice. , 1991, Life sciences.

[14]  David Glick,et al.  Genetic predisposition to adverse consequences of anti–cholinesterases in ‘atypical’ BCHE carriers , 1995, Nature Medicine.

[15]  P. Taylor,et al.  Promoter elements and transcriptional regulation of the acetylcholinesterase gene. , 1993, DNA and cell biology.

[16]  H. Soreq,et al.  Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. , 1995, Pharmacology & therapeutics.

[17]  Y. Iwasaki,et al.  Parkinsonism induced by pyridostigmine , 1988, Acta neurologica Scandinavica.

[18]  A. Friedman,et al.  Intracellular Calcium and Control of Burst Generation in Neurons of Guinea‐Pig Neocortex in Vitro , 1989, The European journal of neuroscience.

[19]  F. Bloom,et al.  Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  H. Gavaghan NIH panel rejects Persian Gulf Syndrome , 1994, Nature.

[21]  A. Gnatt,et al.  Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations. , 1990, The Journal of biological chemistry.

[22]  Y. Li,et al.  Molecular cloning of mouse acetylcholinesterase: Tissue distribution of alternatively spliced mRNA species , 1990, Neuron.

[23]  A. Achiron,et al.  The influence of pyridostigmine administration on human neuromuscular functions : studies in healthy human subjects , 1991 .

[24]  D. A. Brown Slow cholinergic excitation — a mechanism for increasing neuronal excitability , 1983, Trends in Neurosciences.

[25]  Xiao Deyi,et al.  The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against soman poisoning in vivo , 1981 .

[26]  Y. Sharabi,et al.  Survey of symptoms following intake of pyridostigmine during the Persian Gulf war. , 1991, Israel journal of medical sciences.

[27]  J W Fanton,et al.  Acute behavioral toxicity of pyridostigmine or soman in primates. , 1994, Toxicology and applied pharmacology.